Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prucalopride for opioid-induced constipation in adults with chronic non-cancer pain
NL-OMON38356Phase 3Recruiting
- Sponsor
- Movetis
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in opioid-induced constipation (OIC) comparing Prucalopride with Placebo (2 arms). Primary endpoint: Responder rate based on spontaneous bowel movements. Started Jan 2011; status: recruiting.
02
Drugs
prucalopride
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NL-OMON38356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38356.